Synaxys
PrivateLast Round
Seed
Jul 1, 2020
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Synaxys is a biotechnology company that develops 3D human-derived neural platforms for preclinical drug discovery and neuro-pharmacology research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synaxys Comparables
Compare Synaxys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuCyte | 84% | |
| 28bio | 81% | |
| NETRI | 78% | |
Synaxys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2020 |
Synaxys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Créalia Occitanie | Seed |
| Région Occitanie | Seed |
| Bpifrance | Seed |
| Nubbo | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Monthly visitors grew 614% MoM, from 57 to 407.
- Jul 1, 2020
Seed round raised with participation from Bpifrance and Créalia Occitanie.
Synaxys Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synaxys's valuation, stock price, and market status.